Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first ...

The organ-on-chip market offers opportunities driven by the demand for alternatives to animal testing, advances in ...

OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a ...

The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is ...

Researchers have developed a new artificial intelligence (AI) model that can more accurately predict how proteins interact ...

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based tool developed at the University of Oregon could help scientists better ...

Pharma artificial intelligence startup Helical Ltd. announced today that it has raised $10 million in new funding to expand ...

By Sahil Pandey and Puyaan Singh April 14 (Reuters) - Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an ...

Artificial intelligence powerhouse OpenAI Group PBC is lending its expertise to Novo Nordisk A/S in a new partnership ...

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...

Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that it says brings together computational ...